- Home
- PYPD vs CLIR Comparison
PYPD vs CLIR Comparison
Compare PYPD & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- CLIR
- Stock Information
- Founded
- PYPD 2008
- CLIR 2008
- Country
- PYPD Israel
- CLIR United States
- Employees
- PYPD N/A
- CLIR N/A
- Industry
- PYPD Medical/Dental Instruments
- CLIR Industrial Machinery/Components
- Sector
- PYPD Health Care
- CLIR Industrials
- Exchange
- PYPD Nasdaq
- CLIR Nasdaq
- Market Cap
- PYPD 35.3M
- CLIR 35.6M
- IPO Year
- PYPD 2020
- CLIR 2012
- Fundamental
- Price
- PYPD $3.58
- CLIR $0.57
- Analyst Decision
- PYPD Strong Buy
- CLIR Strong Buy
- Analyst Count
- PYPD 5
- CLIR 1
- Target Price
- PYPD $11.40
- CLIR $2.00
- AVG Volume (30 Days)
- PYPD 1.4M
- CLIR 49.8K
- Earning Date
- PYPD 08-13-2025
- CLIR 08-13-2025
- Dividend Yield
- PYPD N/A
- CLIR N/A
- EPS Growth
- PYPD N/A
- CLIR N/A
- EPS
- PYPD N/A
- CLIR N/A
- Revenue
- PYPD N/A
- CLIR $2,895,000.00
- Revenue This Year
- PYPD N/A
- CLIR $27.61
- Revenue Next Year
- PYPD N/A
- CLIR $116.19
- P/E Ratio
- PYPD N/A
- CLIR N/A
- Revenue Growth
- PYPD N/A
- CLIR 10.88
- 52 Week Low
- PYPD $2.30
- CLIR $0.46
- 52 Week High
- PYPD $4.49
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- PYPD 59.00
- CLIR 42.63
- Support Level
- PYPD $3.12
- CLIR $0.53
- Resistance Level
- PYPD $3.75
- CLIR $0.61
- Average True Range (ATR)
- PYPD 0.29
- CLIR 0.06
- MACD
- PYPD 0.01
- CLIR -0.01
- Stochastic Oscillator
- PYPD 69.83
- CLIR 26.67
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.